Companion Animal Pharmaceuticals Market To Surpass USD 32 Billion By 2032, Driven By Innovation And Pet Health Advancements

(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the companion animal pharmaceuticals market include developing advanced biologics and targeted therapies driven by increased pet ownership and rising demands for preventative care. Expanding digital health solutions and navigating regulatory shifts and tariff impacts also offer avenues for strategic growth.

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets's offering.
The Companion Animal Pharmaceuticals Market, which saw a progression from USD 17.53 billion in 2024 to USD 18.85 billion in 2025, is predicted to further grow at a CAGR of 7.82%, reaching an estimated USD 32.04 billion by 2032. Transformed by escalating pet ownership and increased owner expectations, this sector has become a pivotal space for innovation. Urban living trends and dual-income households have amplified the role of pets in family structures, leading to a surge in preventative care and specialty treatment demand.

Strategic Industry Overview

The companion animal pharmaceuticals sector is driven by significant innovation factors, regulatory contexts, and emerging priorities. The regulatory landscape has evolved to support animal welfare while promoting scientific progress through intensified pharmacovigilance requirements. Increased private investment in veterinary biotech also contributes to the development of monoclonal antibodies, vaccines, and diagnostic tools.

Emerging Paradigm Shifts in Drug Development

The landscape is evolving with scientific breakthroughs and technological advancements. Biologics, precision vaccines, and recombinant interferons are redefining treatment approaches, while digital health and telemedicine enhance chronic condition management. New regulatory frameworks balance innovation with safety, emphasizing antimicrobial stewardship. Industry players aiming for competitive advantage must align R&D, regulatory strategies, and digital capacities.

Key Takeaways from This Report

• Biologics and digital integration are reshaping drug development.
• Major economic pressures and regulatory trends affect competitive strategies.
• Strategic initiatives, such as R&D partnerships and digital platforms, drive future growth.
• Understanding market dynamics is essential for identifying opportunities and mitigating risks.

Key Attributes:

Report Attribute	Details
No. of Pages	187
Forecast Period	2025 - 2032
Estimated Market Value (USD) in 2025	$18.85 Billion
Forecasted Market Value (USD) by 2032	$32.04 Billion
Compound Annual Growth Rate	7.8%
Regions Covered	Global

Companies Featured
The companies profiled in this Companion Animal Pharmaceuticals market report include:

• Alivira Animal Health Limited
• Ashish Life Science Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma
• Dechra Pharmaceuticals PLC
• Eco Animal Health Group PLC
• Elanco Animal Health Incorporated
• Endovac Animal Health, LLC
• Hester Biosciences Limited
• Hipra Laboratories, S.A.
• Indian Immunologicals Ltd.
• Kyoritsu Seiyaku Corporation
• Meiji Group
• Merck KGaA
• Neogen Corporation
• Norbrook Laboratories Ltd.
• Orion Corporation
• Phibro Animal Health Corporation
• SkyEc Pharmaceuticals Private Limited
• Stanex Drugs and Chemicals Pvt Ltd.
• Tianjin Ringpu Biotechnology Co., Ltd.
• Veko Care
• Vetbiolix
• Virbac S.A.
• Zoetis Inc.
• Zydus Animal Health

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Companion Animal Pharmaceuticals Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN08122025004107003653ID1110452964